NBMLHD
- World
SpeeDx Partners with Nepean Hospital to Commercialise Respiratory Virus Host Biomarker Assay
SpeeDx newly patented InSignia technology simplifies the measurement of gene expression and will underpin the creation of a simple, standardized…
Read More » - Health
SpeeDx and Nepean Hospital Awarded Federal Funding for Viral Respiratory Biomarker Test
Utilising newly patented InSignia(TM) technology that enhances the measurement of gene expression, the test will be a rapid, high-throughput tool…
Read More »